3h
Vietnam Investment Review on MSNPharma trading landscape undergoing significant shiftThe trade deal between Vietnam and the EU has been making significant impacts on the home pharma market, driven by tariff ...
The pharmaceutical industry is key and needs to focus resources on promoting development to keep pace with modern medical ...
The IT riff here used to win only Emmys and Grammys in, and for adding to, global orchestras of outsourcing, application ...
Novo Nordisk A/S generated 58% of revenue in the US in 2024, while it was almost half for Sanofi SA. Trump ordered his administration ... focus — other Asian countries are more exposed. Vietnam, seen ...
Novo Nordisk A/S generated 58% of revenue in the US in 2024, while it was almost half for Sanofi SA ... other Asian countries are more exposed. Vietnam, seen as an alternative to China since ...
Candidate countries in the Americas are Puerto Rico and Brazil, while those in Asia include Malaysia, Thailand, Singapore, and Vietnam ... been approved to date – Sanofi’s Dengvaxia and ...
Sanofi has bought back a €3bn ($3.1bn) stake held by cosmetics giant L'Oréal, the first of multiple share buybacks the French drugmaker has planned for 2025. L'Oréal was selling 29,556,650 ...
Paris, February 3, 2025. Sanofi today announces the acquisition of 2.3% of its shares from long-standing shareholder L’Oréal. This transaction is part of Sanofi’s share buyback program ...
The FDA granted orphan designation to Sanofi (SNY) US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Published first on ...
This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results